Agilent Brand Specific Scientific Instruments.

Solicitation / RFP / RFQ

This document is a Request for Quotation (RFQ) for the procurement of various Gas Chromatography (GC) and Gas Chromatography-Mass Spectrometer (GC-MS) systems and related configurations. The Drug Enforcement Administration (DEA) requires these systems for its forensic laboratories across the United States to support its mission. The DEA needs equipment that meets accreditation requirements, is compatible with existing methodologies, and can handle reduced laboratory space and analysis time.

The RFQ details specific configurations and capabilities for GC and GC-MS systems, including:

• Various inlet and injection port options (split/split less, multimode, PTV, static headspace).

• Dual injection and detection capabilities (FID and MS).

• Triple mode GC injection port options.

• Specific oven and column specifications (footprint, ramp rates, temperature capabilities, column capacity).

• Energy and gas conservation features (carrier gas selection, helium conservation, sleep mode, leak checking).

• Pressure and flow module specifications.

• Detector specifications (FID, MSD, TCD, ECO, NPD, FPO, SCD, NCO).

• GC/MS software capabilities for data analysis, library searching, and report generation.

• Computer hardware and software compatibility with DEA's Laboratory Information Management System (LIMS).

• Specific configurations for various Agilent GC and GC-MS models, autoinjectors, and workstations.

• The RFQ is not a small business set-aside.

• Delivery is expected by 08/31/2026.

• The contract type is specified as Firm Fixed Price.

• Quotations must be furnished on or before 10:00 am ET on 6/19/2026.

• The document references "See Continuation Sheet(s)" for detailed schedules, implying a comprehensive list of items and specifications.

• Evaluation criteria are not explicitly detailed in the provided pages but are referenced as "Technical and past performance, when combined, are [Contracting Officer state, in accordance with FAR 15.304, the relative importance of all other evaluation factors, when combined, when compared to price.]".

• This RFQ is not a small business set-aside.

• The document includes numerous FAR and agency-specific clauses and provisions related to contracting, security, data handling, and personnel requirements.

• Vendors are required to provide documentation supporting their ability to meet the specifications.

• The document is a Request for Quotation, and submitted quotations are not offers.

Sole Source Justification (SSJ)

This document justifies a sole source procurement for GC-FID and GC-MS instruments for the Drug Enforcement Administration (DEA) Field Laboratories. The procurement is for new lab equipment to replace an expired Blanket Purchase Agreement (BPA). The agency is actively working on a replacement BPA but requires equipment in the interim.

• Procurement of GC-FID and GC-MS instruments.

• Instruments are required for the analysis of seized drugs.

• The DEA laboratory system has developed a specific analytical method utilizing Agilent GC-MS and GC-FID systems, which will be used across all DEA labs.

• The estimated total value is not explicitly stated but falls under simplified procedures for commercial items greater than SAT but not exceeding $7.5 Million (FAR 13.501).

• Period of Performance / Final Delivery Date: 08/31/2026.

• This is a sole source justification, not a solicitation for proposals.

• The justification cites a Brand Specific requirement.

• Market research identified two or more small businesses capable of providing the products through authorized resellers.

• The procurement is considered for a small business set-aside through the open market.

• However, only one vendor, the OEM (Agilent), can provide all required products through GSA.

• The justification is based on FAR 13.501, permitting other than full and open competition for certain commercial items exceeding the simplified acquisition threshold.

• Alternate brands have not been tested or approved for use with the DEA's established analytical method, necessitating standardization.

• The government will continue market research to identify other available vendors for similar products.